☆ 4.7 Article

Pan-cancer analysis combined with experimental validation revealed IL4I1 as an immunological and prognostic biomarker

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

The UCSC Genome Browser database: 2021 update

Jairo Navarro Gonzalez et al.

Summary: The UCSC Genome Browser database has been providing high-quality genomics data visualization and genome annotations for over two decades. New features and data tracks have been continuously added to accommodate advances in genomics and to keep data up-to-date, including new display modes, gene annotations, and tracks for human and mouse genomes. Recently, a genome browser with detailed annotation tracks for the SARS-CoV-2 RNA reference assembly was released.

NUCLEIC ACIDS RESEARCH (2021)

Add to Collection

Article Medicine, Research & Experimental

Single-cell analysis revealed that IL4I1 promoted ovarian cancer progression

Hongyu Zhao et al.

Summary: This study constructed a RiskScore prediction model for ovarian cancer patients by analyzing a single-cell RNA sequencing dataset and prognosis-specific genes. It found that macrophages play a key role in interactions, and downregulation of the IL4I1 gene can inhibit proliferation, migration, and invasion of ovarian cancer cells.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Biology

Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism

Leonie Zeitler et al.

Summary: IL4i1 is an amino acid oxidase that inhibits ferroptotic oxidative cell death by generating I3P from tryptophan, thus activating a cell protective gene expression program.

ELIFE (2021)

Add to Collection

Article Medicine, General & Internal

IL4I1 Is Expressed by Head-Neck Cancer-Derived Mesenchymal Stromal Cells and Contributes to Suppress T Cell Proliferation

Alessio Mazzoni et al.

Summary: Amino acids play a crucial role in cancer metabolism, influencing gene expression and immune responses. Targeting the amino acid oxidase IL4I1 may be a therapeutic strategy to inhibit tumor cell migration and restore anti-tumor immunity.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The current knowledge concerning solid cancer and therapy

Masoud Najafi et al.

Summary: Solid cancers pose a significant global health burden, with various treatment strategies available. Surgical resection, radiotherapy, and chemotherapy are common approaches, but there are challenges in achieving optimal outcomes, leading to ongoing research and the exploration of alternative therapies like immunotherapy and EV therapy.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Integrated analysis reveals the participation of IL4I1, ITGB7, and FUT7 in reshaping the TNBC immune microenvironment by targeting glycolysis

Tao Xu et al.

Summary: The study identified IL4I1, ITGB7, and FUT7 as potential hub genes linking glucose metabolism and cancer-specific immunity in TNBC. These genes may serve as potential targets for enhancing ICB treatment, although their overexpression can lead to poor prognosis.

ANNALS OF MEDICINE (2021)

Add to Collection

Article Oncology

What role for AHR activation in IL4I1-mediated immunosuppression ?

Flavia Castellano et al.

Summary: Although IL4I1 has emerged as a relevant therapeutic target for cancer, its precise role remains poorly understood. IL4I1 inhibits TCR signaling, modulates T cell differentiation, limits T cell proliferation, and shapes the tumor microenvironment in a way that impairs the antitumor immune response. The production of new IL4I1 metabolites may play a role in activating the aryl-hydrocarbon receptor (AHR), but the correlation between IL4I1 expression and AHR activation in human cancers is weak.

ONCOIMMUNOLOGY (2021)

Add to Collection

Review Oncology

Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy

Xu Lei et al.

CANCER LETTERS (2020)

Add to Collection

Review Oncology

Review of precision cancer medicine: Evolution of the treatment paradigm

Apostolia M. Tsimberidou et al.

CANCER TREATMENT REVIEWS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression

Ahmed Sadik et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma

Mei Liu et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Agriculture, Multidisciplinary

Endogenous Indole Pyruvate Pathway for Tryptophan Metabolism Mediated by IL4I1

Xia Zhang et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2020)

Add to Collection

Review Immunology

Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment

Heidi Harjunpaa et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Review Gastroenterology & Hepatology

Biology and significance of alpha-fetoprotein in hepatocellular carcinoma

Peter R. Galle et al.

LIVER INTERNATIONAL (2019)

Add to Collection

Article Biochemistry & Molecular Biology

The Gene Ontology Resource: 20 years and still GOing strong

S. Carbon et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Article Immunology

IL-4-Induced Gene 1: A Negative Immune Checkpoint Controlling B Cell Differentiation and Activation

Lloyd Bod et al.

JOURNAL OF IMMUNOLOGY (2018)

Add to Collection

Review Oncology

Tumour heterogeneity and resistance to cancer therapies

Ibiayi Dagogo-Jack et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Add to Collection

Article Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Add to Collection

Article Biochemistry & Molecular Biology

KEGG: new perspectives on genomes, pathways, diseases and drugs

Minoru Kanehisa et al.

NUCLEIC ACIDS RESEARCH (2017)

Add to Collection

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Add to Collection

Article Oncology

IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma

Lloyd Bod et al.

ONCOIMMUNOLOGY (2017)

Add to Collection

Article Oncology

TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells

Taiwen Li et al.

CANCER RESEARCH (2017)

Add to Collection

Article Chemistry, Medicinal

Evidence for New Light-Independent Pathways for Generation of the Endogenous Aryl Hydrocarbon Receptor Agonist FICZ

Anna Smirnova et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2016)

Add to Collection

Editorial Material Clinical Neurology

Interleukin-4 induced 1 (IL4I1) promotes central nervous system remyelination

Stefano Pluchino et al.

BRAIN (2016)

Add to Collection

Article Developmental Biology

Human spermatozoa possess an IL4I1 L-amino acid oxidase with a potential role in sperm function

B. Houston et al.

REPRODUCTION (2015)

Add to Collection

Review Immunology

Leukocyte Migration into Inflamed Tissues

Sussan Nourshargh et al.

IMMUNITY (2014)

Add to Collection

Article Immunology

IL4I1: an inhibitor of the CD8+ antitumor T-cell response in vivo

Fanette Lasoudris et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2011)

Add to Collection

Article Hematology

Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation

Marie-Laure Boulland et al.

BLOOD (2007)

Add to Collection

Article Immunology

IL-4-induced gene-1 is a leukocyte L-amino acid oxidase with an unusual acidic pH preference and lysosomal localization

JM Mason et al.

JOURNAL OF IMMUNOLOGY (2004)

Add to Collection

Article Pharmacology & Pharmacy

Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor

MA Bittinger et al.

MOLECULAR PHARMACOLOGY (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.